Moreover, even if P4HA1 has been indicated as a prognostic biomarker of several cancers [24, 25, 64], at present no dedicated studies have analysed its sensitivity to TME developed upon metabolic syndrome. This evidence concerns the gene P4HA1 and metabolic syndrome.